References
- Adityanjee, Romine A, Brown E, Thuras P, Lee S, Schultz SC. Quetiapine in patients with borderline personality disorder: an open label trial. Ann Clin Psychiatry 2008; 20:219–226.
- Bellino S, Paradiso E, Bogetto F. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: a pilot study. J Clin Psychiatry 2006; 67:1042–1046.
- Van den Eynde F, Senturk V, Naudts K . Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder. J Clin Psychopharmacol 2008; 28:147–155.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth. Washington, DC: American Psychiatric Association, 1992.
- Tranulis C, Potvin S, Gourgue M, Leblanc G, Mancini-Marie A, Stip E. The paradox of quetiapine in obsessive-compulsive disorder. CNS Spectr 2005; 10:356–361.
- Stamouli S, Lykouras L. Quetiapine induced obsessive-compulsive symptoms: a series of five cases. J Clin Psychopharmacol 2006; 26:396–400.
- Sareen J, Kirshner A, Lander M, Kjeristed KD, Eleff MK, Reiss JP. Do antipsychotics ameliorate or exacerbate obsessive compulsive disorder symptoms? A systematic review. J Affect Disord 2004; 82:167–174.
- Rowe DL. Off-label prescription of quetiapine in psychiatric disorders. Expert Rev Neurother 2007; 7:841–852.